Navigation Links
Starion Achieves Worldwide Distribution of Proprietary Tissue Welding Technology

Researchers in South Africa latest to report patient benefits

SUNNYVALE, Calif., Jan. 31 /PRNewswire/ -- Starion Instruments, a leading surgical device company, today announced that it has extended worldwide distribution of its proprietary tissue welding technology. Physicians in North America, Europe, the Middle East, Africa, and Asia now have access to safe, effective and precise instruments for a wide variety of surgical procedures.

Sealing and dividing soft tissue is an essential part of surgery. Unlike conventional products which use indirect forms of energy: ultrasonic or bipolar radio frequency, Starion instruments perform sealing and dividing with direct heat and pressure. Studies have shown that this method minimizes thermal spread, reduces the risk of collateral damage and decreases patient recovery times.

"Surgeons worldwide are demanding technologies that enhance performance, minimize risk and improve patient outcomes," said Kirt Kirtland, president and chief executive officer of Starion Instruments. "We are excited that our products and value proposition have expanded our reach across the globe."

In South Africa, for example, surgeons are using the company's products in a wide variety of cardiology, general surgery, gynecology, and otolaryngology procedures. The next anticipated areas of expansion are China and Japan, where regulatory approvals are pending.

As Starion's influence grows beyond the U.S., leading researchers from Greece to Taiwan are reporting the benefits of tissue welding technology versus other modalities. Most recently, Lance Maron, MBBCh, FCS (SA), from Netcare Parklane Hospital in Johannesburg, South Africa, presented his findings at the 43rd South African National ENT & SAHNOS Congress.

During the Congress, Maron reported that Starion's forceps are easy to use, cause minimal intra-operative blood loss, facilitate complete removal of tonsils resulting in rapid healing and recovery with less post-operative pain and a fast return to normal diet and school/work.

About Starion Instruments

Starion Instruments is dedicated to developing advanced surgical devices that enhance performance, minimize risk and improve patient outcomes. Starion's instruments employ a proprietary Tissue Welding technology that seals and divides soft tissue while minimizing the risk of collateral damage. Known for their effectiveness, reliability and versatility, Starion's products are used by surgeons worldwide for open and endoscopic cardiac, gynecology, general surgery, otolaryngology and urology procedures. For more information, please visit the company's website at

SOURCE Starion Instruments
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Society of Laproendoscopic Surgeons Names Starion Instruments 2007 Innovator of the Year
2. Surface Logix Achieves Objectives With SLx-4090 in Phase 2a Clinical Trial
3. Pharsight Achieves $7.4 Million in Quarterly Revenue
4. Dalton Medicinal Chemistry Partners Achieves Another Milestone in Collaboration with Boehringer Ingelheim (Canada) Ltd.
5. BIAS Achieves Certified Advantage Partner Level in Oracle PartnerNetwork
6. NOLabs AB Achieves Break-Through in Fight Against MRSA-Bacteria
7. Sigma-Aldrich Achieves Double Accreditation as a Certified Reference Material Producer Following ISO/IEC 17025 and ISO Guide 34
8. BioMS Medical achieves enrollment milestone in U.S. phase III multiple sclerosis trial
9. Dalton Medicinal Chemistry Partners Achieves Milestone in Collaboration with Boehringer Ingelheim (Canada) Ltd.
10. Diplomat Specialty Pharmacy Health Services Division Achieves High Marks in Pilot Program for Chronic Kidney Disease Management
11. Signalife Achieves $1.98 Million Sales Orders Thus Far
Post Your Comments:
(Date:11/25/2015)... CITY , Nov. 25, 2015 /PRNewswire/ - Aeterna ... affirms that its business and prospects remain fundamentally ... , Zoptrex™ (zoptarelin doxorubicin) recently received DSMB recommendation ... to completion following review of the final interim ... Phase 2 Primary Endpoint in men with heavily ...
(Date:11/25/2015)... , November 25, 2015 ... Research Report is a professional and in-depth study ...      (Logo: ) , ... of the industry including definitions, classifications, applications and ... provided for the international markets including development trends, ...
(Date:11/24/2015)... HILLS, N.J. (PRWEB) , ... November 24, 2015 , ... ... as the recipient of the 2016 USGA Green Section Award. Presented annually since 1961, ... golf through his or her work with turfgrass. , Clarke, of Iselin, ...
(Date:11/24/2015)... - iCo Therapeutics ("iCo" or "the Company") (TSX-V: ICO) ... quarter ended September 30, 2015. Amounts, unless specified ... under International Financial Reporting Standards ("IFRS"). ... Andrew Rae , President & CEO of iCo ... value enriching for this clinical program, but also ...
Breaking Biology Technology:
(Date:11/17/2015)... 2015 Paris , ... --> Paris , qui s,est tenu ... le leader de l,innovation biométrique, a inventé le premier ... empreintes sur la même surface de balayage. Jusqu,ici, deux ... pour les empreintes digitales. Désormais, un seul scanner est ...
(Date:11/17/2015)... SOUTH EASTON, Mass. , Nov. 17, 2015 /PRNewswire/ ... "Company"), a leader in the development and sale of ... to the worldwide life sciences industry, today announced it ... closing of its $5 million Private Placement (the "Offering"), ... Offering to $4,025,000.  One or more additional closings are ...
(Date:11/12/2015)... 12, 2015  A golden retriever that stayed healthy ... (DMD) has provided a new lead for treating this ... Broad Institute of MIT and Harvard and the University ... Cell, pinpoints a protective gene ... disease,s effects. The Boston Children,s lab of Lou ...
Breaking Biology News(10 mins):